OssDsign AB
STO:OSSD
Net Margin
OssDsign AB
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
SE |
O
|
OssDsign AB
STO:OSSD
|
1.7B SEK |
-35%
|
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.6T JPY |
23%
|
|
CH |
![]() |
Alcon AG
SIX:ALC
|
31.7B CHF |
11%
|
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
140.7B DKK |
16%
|
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
10.4B USD |
11%
|
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.5B CHF |
12%
|
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP |
9%
|
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
47.4B CNY |
40%
|
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.2B USD |
8%
|
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD |
-6%
|
|
JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
717.5B JPY |
9%
|
OssDsign AB
Glance View
OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on OssDsign AB's most recent financial statements, the company has Net Margin of -35.1%.